Drug recall · April 15, 2026
Isotretinoin Capsules recall
Why: Superpotent and Subpotent
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).
- Lots / codes
Lots 100075305 Exp date 06/2027, 100075512, Exp date 07/2027 & 100076103, Exp date 07/2027 .
- Quantity
- 8376 packages
- Company
- Teva Pharmaceuticals USA, Inc, Parsippany, NJ
- Distribution
- FL, OH, PR & MS
- Initiated
- January 12, 2026 · Voluntary: Firm initiated
- Classified
- April 8, 2026
- Reported
- April 15, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Isotretinoin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.